# SOPHiA GENETICS SA (SOPH)

> Source: Nexqual · https://nexqual.com/SOPH · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, SOPHiA GENETICS SA (SOPH), nexqual.com/SOPH" · informational, not investment advice.

**Price:** USD 7.29 (+3.26% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 7.06 · day 6.83–7.44 · 52w 3.75–8.98 · market cap $621M · NMS

## Key facts
- 1 of 80 tracked superinvestors hold SOPH (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (5 analysts), mean target USD 9.75 (range 7–14).
- Total return with dividends: 1Y +64.2% vs S&P 500 +18.1%; 5Y -54.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-03, EPS estimate USD -0.2, revenue estimate $24.0M.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold SOPH. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Chuck Akre | Akre Capital Management | 0.42% | $21.5M | Unchanged |

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 5 analysts; mean target USD 9.75 (low 7, high 14).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | HC Wainwright & Co. | Reiterated | Buy | $14 |
| 2026-08-05 | HC Wainwright & Co. | Target raised | Buy | $12 → $14 |
| 2026-08-05 | BTIG | Target raised | Buy | $8 → $9 |
| 2026-07-20 | HC Wainwright & Co. | Initiated | Buy | $12 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +64.2% | -54.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +64.5% | -14.6% |
| Volatility (annualized) | 62.2% | 75.9% |
| Max drawdown | -25.7% (Jan 2026→Mar 2026) | -88.0% (Oct 2021→Nov 2022) |

## Peers (Health Information Services)
WEAV (Weave Communications, Inc.) USD 7.39 +0.27% · PHR (Phreesia, Inc.) USD 11.04 +2.70% · EVH (Evolent Health, Inc) USD 4.87 +5.87% · NRC (NRC Health) USD 21.11 +4.66% · CTEV (Claritev Corporation) USD 23.86 +0.59% · CARL (Carlsmed, Inc.) USD 13.95 -3.59%

## More
Full page: https://nexqual.com/SOPH · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt